For: | Varo E, Bañares R, Guilera M. Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study. World J Transplant 2015; 5(1): 26-33 [PMID: 25815269 DOI: 10.5500/wjt.v5.i1.26] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v5/i1/26.htm |
Number | Citing Articles |
1 |
Angel Rubín Suárez, Itxarone Bilbao Aguirre, Javier Fernández-Castroagudin, José Antonio Pons Miñano, Magdalena Salcedo Plaza, Evaristo Varo Pérez, Martín Prieto Castillo. Recomendaciones de uso de everolimus en el trasplante hepático. Gastroenterología y Hepatología 2017; 40(9): 629 doi: 10.1016/j.gastrohep.2017.05.008
|
2 |
Maria Cristina Morelli, Maria Rendina, Gaetano La Manna, Carlo Alessandria, Luisa Pasulo, Ilaria Lenci, Sherrie Bhoori, Piergiorgio Messa, Luigi Biancone, Loreto Gesualdo, Francesco Paolo Russo, Salvatore Petta, Patrizia Burra. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN). Digestive and Liver Disease 2021; 53: S49 doi: 10.1016/j.dld.2021.03.035
|
3 |
Umberto Cillo, Wolf O. Bechstein, Gabriela Berlakovich, Philipp Dutkowski, Frank Lehner, Silvio Nadalin, Faouzi Saliba, Hans J. Schlitt, Johann Pratschke. Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression. Transplantation Reviews 2018; 32(3): 142 doi: 10.1016/j.trre.2018.04.001
|
4 |
Angel Rubín Suárez, Itxarone Bilbao Aguirre, Javier Fernández-Castroagudin, José Antonio Pons Miñano, Magdalena Salcedo Plaza, Evaristo Varo Pérez, Martín Prieto Castillo. Recommendations of everolimus use in liver transplant. Gastroenterología y Hepatología (English Edition) 2017; 40(9): 629 doi: 10.1016/j.gastre.2017.10.006
|
5 |
Flor Nogueras López, Patricia Abellan Alfocea, Eva Julissa Ortega Suazo, Maria Angeles López Garrido, Antonio Becerra Massare, Ana María Gila Medina, Eduardo Redondo Cerezo, M. Dolores Espinosa Aguilar. Impact of Everolimus-based Immunosuppression on Renal Function in Liver Transplant Recipients. Transplantation Proceedings 2020; 52(2): 556 doi: 10.1016/j.transproceed.2019.12.012
|
6 |
Mohamed Hashim, Ayman Alsebaey, Amr Ragab, Hossam Eldeen Soliman, Imam Waked. Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study. Annals of Hepatology 2020; 19(5): 541 doi: 10.5604/01.3001.0012.2246
|
7 |
José Ignacio Herrero , Valentín Cuervas-Mons, Miguel Ángel Gómez-Bravo, Joan Fabregat, Alejandra Otero, Itxarone Bilbao, María Magdalena Salcedo, María Luisa González-Diéguez, Jose Ramón Fernández, María Trinidad Serrano, Miguel Jiménez, Juan Miguel Rodrigo, Isidoro Narváez, Gloria Sánchez . Prevalence and progression of chronic kidney disease after a liver transplant: a prospective, real-life, observational, two-year multicenter study. Revista Española de Enfermedades Digestivas 2018; 110: 538 doi: 10.17235/reed.2018.5431/2017
|
8 |
|
9 |
Itxarone Bilbao, Magdalena Salcedo, Miguel Angel Gómez, Carlos Jimenez, Javier Castroagudín, Joan Fabregat, Carolina Almohalla, Ignacio Herrero, Valentín Cuervas‐Mons, Alejandra Otero, Angel Rubín, Manuel Miras, Juan Rodrigo, Trinidad Serrano, Gonzalo Crespo, Manuel De la Mata, Javier Bustamante, M. Luisa Gonzalez‐Dieguez, Antonia Moreno, Isidoro Narvaez, Magda Guilera. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain. Liver Transplantation 2015; 21(8): 1056 doi: 10.1002/lt.24172
|